Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It is easy to get caught up in short-term share price moves. But the ASX shares that often deliver the strongest long-term returns are those quietly expanding their addressable markets, deepening customer relationships, and reinvesting to stay ahead of competitors.

With that in mind, let's now take a look at a couple of ASX growth stocks that could realistically be much larger businesses by 2030 than they are today.

Man pointing an upward line on a bar graph symbolising a rising share price.

Image source: Getty Images

Pro Medicus Ltd (ASX: PME)

Pro Medicus is arguably one of the most impressive growth stories on the Australian share market and it has achieved this by doing one thing exceptionally well.

Its Visage medical imaging platform is increasingly being adopted by large hospital networks, particularly in the United States. Speed, scalability, and reliability are critical in medical imaging, and once the software is embedded into clinical workflows, it becomes very difficult to replace.

The long-term opportunity remains significant. Imaging volumes continue to rise, data sets are becoming larger and more complex, and healthcare providers are battling radiologist shortages and under constant pressure to improve efficiency. All of this plays directly into Pro Medicus' strengths.

If adoption continues to broaden globally, the business could be servicing a far larger slice of the healthcare system by the end of the decade.

In addition, the company is expanding into other ologies, such as cardiology and pathology, giving it a significant growth runway over the next decade.

Catapult Sports Ltd (ASX: CAT)

Another ASX growth stock that could grow materially in the future is Catapult Sports.

It specialises in wearable tracking technology and performance analytics used by professional sporting teams and organisations around the world. These tools help teams optimise performance, manage workloads, and reduce injury risk, which are areas where marginal gains can have a significant impact.

What makes Catapult particularly interesting over the long term is the size of its opportunity relative to its current scale. The global professional sports technology market is expected to grow strongly through to the end of the decade, as data and analytics become standard tools across more sports and competitions.

As mentioned here, Bell Potter highlights that "the pro sports technology market is currently valued at US$36bn in 2025 and is forecast to double to US$72bn by 2030." This bodes well for Catapult, especially given how it is a market leader.

As adoption deepens and operating leverage improves, the business has the potential to generate significantly higher earnings than it does today.

Motley Fool contributor James Mickleboro has positions in Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Sports. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Catapult Sports. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These valuations are too good to ignore! I'd buy these ASX shares today

I think these businesses have very attractive futures.

Read more »

A man and woman jump in the air and high five with both hands on a road after running.
Growth Shares

2 battered ASX growth shares that could double in value or more

Brokers are strikingly bullish and tip up to 180% upside.

Read more »

Cropped shot of a young female scientist working on her computer in the laboratory.
Healthcare Shares

Could Telix shares be a millionaire-maker stock?

Telix looks a compelling growth story, with brokers eyeing more than 150% upside.

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 top ASX shares I'd buy right now in this March madness

The valuations these businesses are now trading at are too good to ignore!

Read more »

A man has a surprised and relieved expression on his face.
Growth Shares

3 undervalued ASX stocks to consider buying immediately

Analysts are tipping huge upsides ahead for these undervalued shares.

Read more »

Man jumps for joy in front of a background of a rising stocks graphic.
Healthcare Shares

3 ASX healthcare stocks tipped to soar over 100% higher this year

These ASX shares are on my radar this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Growth Shares

2 ASX growth stocks down 40% to 60% to buy now

Big sell-offs can sometimes create compelling investment opportunities.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Growth Shares

Brokers rate these 2 top ASX shares as buys in March

Here’s why experts are confident about these businesses for the long-term.

Read more »